Nanoscribe, a BICO company, introduces the Extra Large Features (XLF) Print Set, to expand the manufacturing range for its high-precision 3D printer Quantum X shape from nano- and microscale structures to millimeter- and centimeter-sized objects, while maintaining particularly complex structures and filigree details as is the case in many biomedical and microfluidic applications. But above all, the new XLF Print Set speeds up high-precision 3D printing many times over, making Quantum X shape the preferred choice for batch production of voluminous millimeter- and even centimeter-sized objects for the first time.
Thanks to the inherent advantages of Two-Photon Polymerization (2PP), this high-precision 3D printing technology is proven to be at least 100 times more precise than comparable technologies such as high-resolution SLA and DLP or projection micro-stereolithography (PµSL). Until now, 2PP was limited to object sizes of just a few millimeters. With the XLF Print Set, the high-precision 3D printing technology can now be seamlessly extended to centimeter-sized objects, with precision typically 2 to 5 times higher than comparable microfabrication technologies. In a single pass, objects up to 30 cubic centimeters can be produced.
“The XLF Print Set brings a whole new world of opportunities to the Quantum X shape,” says Dr. Michael Thiel, Chief Science Officer and co-founder of Nanoscribe. “First and foremost, you gain tremendous speed in manufacturing large print quantities of voluminous objects in one batch,” Thiel summarizes one key benefit of the new XLF Print Set.
The Nanoscribe Quantum X shape is a superior laser-based 3D printing platform with straightforward processes and reliable workflows. With the addition of the XLF Print Set users can now print large parts with filigree features or even many millimeter-sized parts with complex structures or finest details. The set contains a new air objective with a magnification factor of 5x, resulting in an increased print field diameter of up to 3,200 µm and a comparatively large working distance of 18.5 mm. Combined with a high scanning speed, adjustable voxel sizes, and a highly sensitive photopolymer resin, the XLF Print Set provides a comprehensive solution for high-precision 3D printing in the milli- and centimeter range. With this addition the Quantum X shape is an attractive solution for prototyping and manufacturing mechanical parts such as millimeter-sized connectors and housings, microfluidic structures, and scaffolds for biomedical research.
For further information, please contact:
Avijit Minocha, Head of Marketing, BICO
Phone (US): +1 (617) 637 5372
This information was submitted for publication, through the agency of the contact persons set out above, on March, 9, 2022 at 10:00 (CET).
The medium-sized company develops and produces 3D printers and grayscale lithography systems as well as specially developed printing materials and application-specific solutions for various microfabrication applications. The specialist for additive manufacturing of high-precision structures and objects on the nano-, micro- and mesoscale was founded in 2007 as a spin-off of the Karlsruhe Institute of Technology (KIT) and is part of the BICO Group since June 2021. More than 3,000 users and operators at top universities and innovative companies worldwide benefit from the groundbreaking technology and application tailored solutions for 3D Microfabrication. Nanoscribe has created its strong market leading position through high quality engineering and agility to continuously develop its products to meet customers’ high expectations. Visit nanoscribe.com for more information.
Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better.
The company has a focus on developing technologies that will advance Health 4.0 Next Generation Core Industry Ecosystems that enable tissue engineering, diagnostics, multiomics, and cell line development. BICO’s technologies enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health.
The Group’s instruments in the field amounts to 25,000, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 9,500 publications. BICO is listed on Nasdaq Stockholm under BICO. www.bico.com